[HTML][HTML] 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

WEE Eberhardt, D De Ruysscher, W Weder… - Annals of …, 2015 - Elsevier
To complement the existing treatment guidelines for all tumour types, ESMO organises
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …

Phase III study of surgery versus definitive concurrent chemoradiotherapy boost in patients with resectable stage IIIA (N2) and selected IIIB non–small-cell lung cancer …

WEE Eberhardt, C Pöttgen, TC Gauler… - Journal of Clinical …, 2015 - ascopubs.org
Purpose Concurrent chemoradiotherapy with or without surgery are options for stage IIIA
(N2) non–small-cell lung cancer. Our previous phase II study had shown the efficacy of …

Cancer screening in the elderly: a review of breast, colorectal, lung, and prostate cancer screening

AA Kotwal, MA Schonberg - The Cancer Journal, 2017 - journals.lww.com
There are relatively limited data on outcomes of screening older adults for cancer; therefore,
the decision to screen older adults requires balancing the potential harms of screening and …

Institutional clinical trial accrual volume and survival of patients with head and neck cancer

EJ Wuthrick, Q Zhang, M Machtay… - Journal of Clinical …, 2015 - ascopubs.org
Purpose National Comprehensive Cancer Network guidelines recommend patients with
head and neck cancer (HNC) receive treatment at centers with expertise, but whether …

[HTML][HTML] Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a …

M Moehler, J Heo, HC Lee, WY Tak, Y Chao… - …, 2019 - Taylor & Francis
ABSTRACT Pexastimogene devacirepvec (Pexa-Vec) is a vaccinia virus-based oncolytic
immunotherapy designed to preferentially replicate in and destroy tumor cells while …

Impact of national cancer policies on cancer survival trends and socioeconomic inequalities in England, 1996-2013: population based study

A Exarchakou, B Rachet, A Belot, C Maringe… - Bmj, 2018 - bmj.com
Objective To assess the effectiveness of the NHS Cancer Plan (2000) and subsequent
national cancer policy initiatives in improving cancer survival and reducing socioeconomic …

European Respiratory Society guideline on various aspects of quality in lung cancer care

TG Blum, RL Morgan, V Durieux… - European …, 2023 - Eur Respiratory Soc
This European Respiratory Society guideline is dedicated to the provision of good quality
recommendations in lung cancer care. All the clinical recommendations contained were …

European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma

N Concin, F Planchamp, NR Abu-Rustum… - International Journal of …, 2021 - ijgc.bmj.com
Background Quality of surgical care as a crucial component of a comprehensive multi-
disciplinary management improves outcomes in patients with endometrial carcinoma …

European cancer organisation essential requirements for quality cancer care (ERQCC): lung cancer

T Berghmans, Y Lievens, M Aapro, AM Baird… - Lung Cancer, 2020 - Elsevier
Abstract European Cancer Organisation Essential Requirements for Quality Cancer Care
(ERQCC) are written by experts representing all disciplines involved in cancer care in …

Urban-rural differences in receipt of cancer surgery at high-volume hospitals and sensitivity to hospital volume thresholds

H Ramian, Z Sun, J Yabes, B Jacobs… - JCO Oncology …, 2024 - ascopubs.org
PURPOSE There is strong evidence that hospital volume is associated with improved
outcomes for patients undergoing cancer surgery. Lack of access to high-volume hospitals …